Topics

The truth about the marketing and promotion of medicines

10:00 EDT 3 Oct 2019 | PhRMA

Despite what critics say, the U.S. biopharmaceutical industry spends three times more on the research and development (R&D) of new treatments and cures than on the marketing and promotion of medicines. Misleading claims on how much is spent on marketing and promotion perpetuate a narrative riddled with inaccurate data and information and results in policy proposals that can harm patients.

Original Article: The truth about the marketing and promotion of medicines

NEXT ARTICLE

More From BioPortfolio on "The truth about the marketing and promotion of medicines"

Quick Search